Abdominal/gastrointestinal complaints are the most prevalent initial symptoms in DLBCL, reported by 26% of patients. Peripheral lymphadenopathy and testicular tumors are associated with low-risk ...
Hosted on MSN
Recent Developments in Diffuse Large B-Cell Lymphoma
Recent noteworthy reports on diffuse large B-cell lymphoma (DLBCL) include positive survival results with an antibody-drug conjugate in relapsed/refractory disease, FDA issues with a randomized trial, ...
—This large, population-based study of patients with PP-DLBCL assessed prognostic factors and confirmed that certain common therapeutic interventions can modify disease progression. Being age 65 years ...
Reflecting on a patient experience during a fellowship in 2015, Suchitra Sundaram, MD, notes how the standard treatment for stage IV ABC-subtype diffuse large B-cell lymphoma (DLBCL) was R-CHOP ...
Please provide your email address to receive an email when new articles are posted on . In this video, Leo I. Gordon, MD, FACP, discusses highlights from a debate at Lymphoma, Leukemia & Myeloma ...
About 1 in 5 patients with B-cell lymphoma treated with loncastuximab develop skin-related adverse events, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results